Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell transcriptomic mapping of patient-derived primary liver cancer organoids reveals molecular subtypes and guides precision drug targeting. | Cell Oncol (Dordr) | 2026 | 41838232 | PubTator, text mining | PubMed |
| Development and validation of a gemcitabine sensitivity-related long noncoding RNA signature for predicting the prognosis and subtypes of bladder cancer. | Transl Androl Urol | 2026 | 41809777 | PubTator, text mining | PubMed |
| Targeted native long-read sequencing of DNA methylation alterations following CRISPR-Cas9-induced double-strand breaks in human cells. | BMC Res Notes | 2026 | 41808208 | PubTator, text mining | PubMed |
| Epigenomic and Metabolic Interplay in the Development of Metastatic Brain Tumors. | Oncol Res | 2026 | 41799524 | PubTator, text mining | PubMed |
| LncRNAs: key regulators and molecular mechanisms in lung cancer radiosensitivity. | Open Med (Wars) | 2026 | 41798908 | PubTator, text mining | PubMed |
| WNT7B drives a program for pancreatic cancer subtype switching and progression. | iScience | 2026 | 41797924 | PubTator, text mining | PubMed |
| Ferroptosis in cardiovascular diseases: molecular mechanisms and a novel therapeutic target. | Mol Biomed | 2026 | 41795043 | PubTator, text mining | PubMed |
| A bioinformatics and experimental study toward new therapeutic strategies: CXCL8 in gout progression. | Medicine (Baltimore) | 2026 | 41790703 | PubTator, text mining | PubMed |
| Clinical significance of LINC00893 and miR-103a-3p in type 2 diabetes mellitus patients with coronary heart disease. | Diab Vasc Dis Res | 2026 | 41746985 | PubTator, text mining | PubMed |
| Inside the Battle Against Acute Myeloid Leukemia: Biology, Breakthroughs, and Hope. | Cells | 2026 | 41744781 | PubTator, text mining | PubMed |
| Long non-coding RNAs in the exosomal network: dual roles and clinical implications in cancer. | Anim Cells Syst (Seoul) | 2026 | 41737608 | PubTator, text mining | PubMed |
| The interplay of dietary sugar, chronic inflammation, and bladder cancer: mechanistic insights, evidence, and prevention strategies. | Front Immunol | 2026 | 41737225 | PubTator, text mining | PubMed |
| Molecular classification and prognosis study of pancreatic ductal adenocarcinoma through multi-omics integrated clustering analysis. | PeerJ | 2026 | 41727227 | PubTator, text mining | PubMed |
| Nanoparticles Targeting the Tumor Microenvironment for the Treatment of Osteosarcoma: Recent Progress and Perspectives. | Int J Nanomedicine | 2026 | 41725887 | PubTator, text mining | PubMed |
| Detecting Occult Sentinel Node Metastases in HNSCC: The Emerging Role of lncRNAs as Biomarkers and Future Perspectives for USgFNAB Molecular Profiling. | Cancers (Basel) | 2026 | 41681899 | PubTator, text mining | PubMed |
| HDACi induces apoptosis of osteosarcoma cells by inhibiting the MAPK pathway. | Sci Rep | 2026 | 41617752 | PubTator, text mining | PubMed |
| NRF2: Master regulator of cellular homeostasis and therapeutic vulnerability in cancer. | Redox Biol | 2026 | 41616572 | PubTator, text mining | PubMed |
| Long non-coding RNAs and therapeutic resistance in multiple myeloma: from molecular insights to clinical applications. | Clin Exp Med | 2026 | 41547689 | PubTator, text mining | PubMed |
| Long non-coding RNA UCA1 modulates SMARCA2-containing SWI/SNF chromatin remodeling complexes in human colorectal cancer. | iScience | 2026 | 41537001 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis of long non-coding RNA regulatory networks in chronic myeloid leukemia resistance and leukemic stem cell persistence. | Comput Biol Chem | 2026 | 41151234 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=2